Open-Label Pilot Study of the Efficacy and Safety of Vusion Ointment for the Treatment of Intertrigo



Status:Completed
Conditions:Dermatology
Therapuetic Areas:Dermatology / Plastic Surgery
Healthy:No
Age Range:12 - 75
Updated:10/14/2017
Start Date:April 2010
End Date:May 2011

Use our guide to learn which trials are right for you!

The purpose of this study is to determine if people with moist, red, patches on their skin in
body folds would benefit treatment of those areas with an FDA-approved drug called Vusion.

Intertrigo is an inflammatory condition of skin folds, induced or aggravated by heat,
moisture, maceration, friction, or lack of air circulation. It is typically chronic with
insidious onset of itching, burning, and stinging within the affected skin folds. Intertrigo
frequently worsened or colonized by infection, which most commonly is candidal but also may
be bacterial, fungal, or viral. The etiology of diaper dermatitis shows significant overlap
with that of intertrigo. Vusion ointment, a highly effective treatment for diaper dermatitis,
has been used by physicians for the treatment of intertrigo; however, there is a paucity of
data in the literature regarding the use of Vusion ointment in this indication.

This study is the first to formally investigate the efficacy and safety of Vusion ointment
for the treatment of intertrigo.

Inclusion Criteria:

- Evidence of intertrigo

Exclusion Criteria:

- Pregnancy

- Use of systemic or topical antifungal or corticosteroid treatment in the previous 14
days or during the 3-month treatment period

- allergy of sensitivity to Vusion

- undergoing warfarin anticoagulation

- alcohol or drug abuse

- Investigator determines they cannot particpate

- history of non-compliance or poor cooperation

- participation in an investigaitonal drug study within 30 days of Baseline Visit
We found this trial at
1
site
Montclair, New Jersey 07042
?
mi
from
Montclair, NJ
Click here to add this to my saved trials